Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): An initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC)

Pediatric Blood and Cancer

Volumn 61, Issue 5, 2014, Pages 869-874

  Williams, David A ^a   Bennett, Carolyn ^b   Bertuch, Alison ^c   Bessler, Monica ^d   Coates, Thomas ^e   Corey, Seth ^f   Dror, Yigal ^g   Huang, James ^h   Lipton, Jeffrey ^i,j   Olson, Timothy S ^d   Reiss, Ulrike M ^k   Rogers, Zora R ^l   Sieff, Colin ^a   Vlachos, Adrianna ^i,j   Walkovich, Kelly ^m   Wang, Winfred ^k   Shimamura, Akiko ⁿ  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e CHILDREN S HOSPITAL LOS ANGELES   (United States)

^f CHILDREN'S MEMORIAL HOSPITAL   (United States)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Northwell Health   (United States)

^j FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^k ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^l UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^m UNIVERSITY OF MICHIGAN   (United States)

ⁿ Fred Hutchinson Cancer Research Center   (United States)

more..

Author keywords

Acquired aplastic anemia; Diagnosis; NAPAAC; Treatment

Indexed keywords

ACICLOVIR; ANTIFUNGAL AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN A; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN; HEMOPOIETIC GROWTH FACTOR; LEVOFLOXACIN; METHYLPREDNISOLONE; PENTAMIDINE; THYMOCYTE ANTIBODY; VORICONAZOLE;

APLASTIC ANEMIA; ARTICLE; BLOOD TRANSFUSION; BONE MARROW; CHILDHOOD DISEASE; CLINICAL EVALUATION; CONSENSUS; CYTOGENETICS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DONOR; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENETIC ANALYSIS; HEALTH CARE SURVEY; HEALTH CARE UTILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PATIENT CARE; PATIENT REFERRAL; PNEUMOCYSTOSIS; PRIORITY JOURNAL; PROPHYLAXIS; RELAPSE; SIBLING; THROMBOCYTE; TREATMENT FAILURE; TREATMENT RESPONSE;

ACQUIRED APLASTIC ANEMIA; DIAGNOSIS; NAPAAC; TREATMENT;

ADOLESCENT; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE SURVEYS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; NORTH AMERICA; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; SIBLINGS;

EID: 84895753783     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24875     Document Type: Article

References (22)

1. Young NS, Kaufman DW. The epidemiology of acquired aplastic anemia. Haematologica 2008; 93:489-492.
2. Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic anemia: A prospective study of the effect of early marrow transplantation on acute mortality. Blood 1976; 48:63-70.
3. Mary JY, Baumelou E, Guiguet M. Epidemiology of aplastic anemia in france: A prospective multicentric study. The french cooperative group for epidemiological study of aplastic anemia. Blood 1990; 75:1646-1653.
4. Montane E, Ibanez L, Vidal X, et al. Epidemiology of aplastic anemia: A prospective multicenter study. Haematologica 2008; 93:518-523.
5. Guinan EC. Acquired aplastic anemia in childhood. Hematol Oncol Clin North Am 2009; 23:171-191.
6. Marsh JC, Ball SE, Cavenagh J, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol 2009; 147:43-70.
7. Scheinberg P, Young NS. How i treat acquired aplastic anemia. Blood 2012; 120:1185-1196.
8. Samarasinghe S, Steward C, Hiwarkar P, et al. Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: A united kingdom multicentre retrospective experience. Br J Haematol 2012; 157:339-346.
9. Scheinberg P, Nunez O, Weinstein B, et al. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med 2011; 365:430-438.
10. Yoshimi A, Niemeyer CM, Fuhrer MM, et al. Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children. Blood 2013; 121:860-861.
11. Scheinberg P, Wu CO, Nunez O, et al. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine. J Pediatr 2008; 153:814-819.
12. Samarasinghe S, Webb DK. How i manage aplastic anaemia in children. Br J Haematol 2012; 157:26-40.
13. Tichelli A, Schrezenmeier H, Socie G, et al. A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (atg), cyclosporine, with or without g-csf: A study of the saa working party of the european group for blood and marrow transplantation. Blood 2011; 117:4434-4441.
14. Valdez JM, Scheinberg P, Young NS, et al. Infections in patients with aplastic anemia. Semin Hematol 2009; 46:269-276.
15. Quillen K, Wong E, Scheinberg P, et al. Granulocyte transfusions in severe aplastic anemia: An eleven-year experience. Haematologica 2009; 94:1661-1668.
16. Gluckman E, Rokicka-Milewska R, Hann I, et al. Results and follow-up of a phase iii randomized study of recombinant human-granulocyte stimulating factor as support for immunosuppressive therapy in patients with severe aplastic anaemia. Br J Haematol 2002; 119:1075-1082.
17. Kojima S, Hibi S, Kosaka Y, et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 2000; 96:2049-2054.
18. Chun C, Fang JP, Xue HM, et al. Allogeneic hematopoietic stem cell transplantation for childhood aplastic anemia: Prospective trial in china. Transfus Apher Sci 2011; 44:41-47.
19. Yoshida N, Yagasaki H, Hama A, et al. Predicting response to immunosuppressive therapy in childhood aplastic anemia. Haematologica 2011; 96:771-774.
20. Jeong DC, Chung NG, Kang HJ, et al. Epidemiology and clinical long-term outcome of childhood aplastic anemia in korea for 15 years: Retrospective study of the korean society of pediatric hematology oncology (kspho). J Pediatr Hematol Oncol 2011; 33:172-178.
21. Kamio T, Ito E, Ohara A, et al. Relapse of aplastic anemia in children after immunosuppressive therapy: A report from the japan childhood aplastic anemia study group. Haematologica 2011; 96:814-819.
22. Fuhrer M, Rampf U, Baumann I, et al. Immunosuppressive therapy for aplastic anemia in children: A more severe disease predicts better survival. Blood 2005; 106:2102-2104.